C1QL3 and type 2 diabetes mellitus: In conclusion, our study demonstrates an association between lower circulating levels of CTRP3 and CTRP13 with increased risk of CAD and T2DM, suggesting that these metabolic conditions are mediated at least in part through the effects of CTRP3 and CTRP13.